Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 13.11% ...

Topline data from Phase 3 REFOCUS-ALZ study of simufilam in patients with mild-to-moderate Alzheimer's disease expected late first-quarter/early second-quarter 2025 Implementing cost curtailment inclu ...

Cassava Sciences is laying off 10 employees —a third of its workforce—as the biotech seeks to conserve cash in the wake of ...

Cassava Science provided a business update. In November 2024, Cassava reported that the topline results from the Phase 3 RETHINK-ALZ study ...

Topline data from Phase 3 REFOCUS-ALZ study of simufilam in patients with mild-to-moderate Alzheimer’s disease expected late ...

We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...

An international collaboration has announced a public-private partnership to develop high-yielding pest-and disease-resistant cassava, maize and potatoes to benefit more than 500,000 farm households ...

H.C. Wainwright has recently reduced Cassava Sciences Inc (SAVA) stock to Neutral rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 8, 2024, H.C. Wainwright had ...

NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn ...

Robbins LLP reminds investors that a class action was filed against Cassava Sciences, Inc. (NASDAQ: SAVA) for wrongdoing between February 7, 2024 ...

Class Action, Consumer Services, GlobeNewswire, Law & Legal Issues | NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law F ...